Objective: To describe the management and outcomes of a population-based cohort of patients with pancreatic cancer in Victoria, Australia.
Design, Setting And Patients: Retrospective study based on questionnaires completed from medical histories of patients diagnosed with pancreatic cancer during 2002-2003 in Victoria who were identified from the Victorian Cancer Registry and followed up for 6 years.
Main Outcome Measures: Proportion of patients receiving each form of treatment, 30-day mortality, median survival, and 5-year and 6-year survival.
IgG4-related systemic disease (IRSD) is a recently described entity with protean manifestations. We describe a patient who developed inflammation and fibrosis in multiple organs over 20 years, sequentially involving his pancreas, bile ducts, gallbladder, submandibular and lacrimal glands, and kidneys. He had an elevated serum IgG4 level.
View Article and Find Full Text PDF